XSC
ARNA

X-Square Capital’s Arena Pharmaceuticals Inc ARNA Stock Holding History

X-Square Capital’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-20,225
Closed -$907K – 74
2019
Q1 		$907K Buy
20,225
+2,810
+16% +$129K 0.62% 35
2018
Q4 		$678K Hold
17,415
– – 0.53% 42
2018
Q3 		$801K Hold
17,415
– – 0.53% 44
2018
Q2 		$760K Buy
17,415
+250
+1% +$10.7K 0.57% 37
2018
Q1 		$678K Sell
17,165
-15,190
-47% -$591K 0.72% 35
2017
Q4 		$1.1M Buy
+32,355
New +$922K 1.16% 30

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

X-Square Capital's ARNA Position: Q2 2019 in Review

X-Square Capital sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2019, closing a stake of 20,225 shares — an estimated $907K sold.

X-Square Capital first reported a position in ARNA in Q4 2017 and held it in 6 quarters. The position peaked at $1.1M in Q4 2017. 215 funds tracked by Wall St. Rank hold ARNA as of Q2 2019.

  • X-Square Capital reported no remaining Arena Pharmaceuticals Inc position as of Q2 2019 after selling out during the quarter.
  • X-Square Capital sold 20,225 Arena Pharmaceuticals Inc shares in Q2 2019, an estimated $907K.
  • X-Square Capital first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 6 quarters.
  • X-Square Capital's Arena Pharmaceuticals Inc position peaked at $1.1M in Q4 2017.
  • 215 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2019.

Based on X-Square Capital's 13F filing for Q2 2019, filed 14 Aug 2019.